Where warranties, indemnities and W&I insurance in an Asia deal stands now

The Asia deal market has a documentation problem that most advisers on either side of the transaction do not acknowledge until it is too late. Warranties are negotiated in English, governed by Hong Kong or English law, and signed by a BVI or Cayman holding entity. The assets that matter – a manufacturing facility in Guangdong, a distribution network in Southeast Asia, a technology licence held by a variable interest entity structure – sit in jurisdictions where a warranty claim, even if won, may be difficult to enforce, and where the legal system's relationship with contractual risk allocation looks nothing like the common-law assumptions embedded in the warranty schedule.

Warranties, indemnities and warranty and indemnity insurance – collectively referred to here as W&I cover – in an Asia cross-border deal are governed by the law chosen by the parties in the transaction documents, typically Hong Kong or English law, with enforcement running through the deal vehicle's jurisdiction and, where assets are Mainland-situated, through the reciprocal enforcement regime that has been in operation since 29 January 2024 under the Mainland Judgments in Civil and Commercial Matters (Reciprocal Enforcement) Ordinance (Cap. 645). The practical question is not which law governs the warranty – the parties choose that. The question is whether a warranty judgment or insurance recovery can reach the assets that have actually lost value.

This analysis covers four connected positions: what is commercially at stake; how the governing instruments and the cross-border interface operate; how the risk picture differs across the two principal systems our clients encounter; and where, on our current read of the deal environment, the structural risk sits.

What is commercially at stake in an Asia W&I deal?

Warranties and indemnities in a sale and purchase agreement allocate the risk of unknown or undisclosed liabilities between a buyer and a seller. A warranty is a statement of fact that, if false, gives the buyer a damages claim. An indemnity is a promise to make good a defined category of loss, pound for pound, without the buyer having to prove diminution in value. The commercial difference matters: indemnities are used for identified risk categories – tax exposures, pending litigation, environmental liabilities, title defects in specific assets – while warranties carry the residual informational risk of the transaction.

In an Asia deal, the commercial stakes on the warranty side are materially higher than in a comparable European transaction. This is because due diligence in Mainland China and across parts of Southeast Asia is structurally incomplete. Public registries are inconsistently maintained. Financial statements prepared under local standards diverge from IFRS in ways that affect how warranty breaches are measured. Auditors' working papers are sometimes inaccessible. The consequence is that a buyer paying a market price for an Asian target is accepting a level of informational risk that the warranty schedule alone cannot neutralise.

W&I insurance emerged in the Asia market as a direct response to this asymmetry. A buy-side policy passes the warranty-breach risk to an insurer, removes the seller's exposure on clean exit deals, and enables the buyer to claim against a creditworthy counterparty rather than a seller who may have distributed the proceeds and dissolved the holding entity by the time a breach is discovered. For private equity exits, for founder-led disposals, and for transactions with a strategic acquirer unwilling to hold back a meaningful escrow, W&I insurance has become the standard mechanism in deals above a certain transaction value – parties should verify the current policy-minimum threshold with their insurer, as it has been moving in the Asian market.

How does the governing instrument and the cross-border interface actually work?

The warranty and indemnity provisions in an Asia deal sit in the sale and purchase agreement, which will typically be governed by Hong Kong law or English law. Either system is a mature common-law regime with a developed body of case authority on warranty construction, the duty to disclose, and the measure of damages for breach. The choice between the two is usually practical: Hong Kong governing law is appropriate where Hong Kong is the forum, the holding entity is incorporated there, and the parties have counsel in the city. English governing law is sometimes preferred by European sellers or funds with English-law standard documents.

The cross-border interface bites at two points. First, when a warranty claim is litigated or arbitrated and the judgment or award needs to be enforced against a seller who has assets in the Mainland, the enforcement route runs through the regime established by the Mainland Judgments in Civil and Commercial Matters (Reciprocal Enforcement) Ordinance (Cap. 645). That ordinance came into force on 29 January 2024, replacing the narrower 2008 choice-of-court regime. Under the current regime, a judgment made on or after that date by the Court of First Instance is registrable in the Mainland courts without the need to demonstrate that the parties had a prior exclusive jurisdiction agreement. The old requirement has been removed. What remains is a connection-based test, plus an exclusion list that covers certain categories of claim – parties should review the exclusion list carefully in the context of their specific warranty claim.

Second, where the deal uses arbitration rather than court proceedings – which is common in M&A transactions with Mainland counterparties – the enforcement route runs through the 1999 Arrangement and the 2020 Supplemental Arrangement on mutual enforcement of arbitral awards. Since the 2021 amendment, simultaneous enforcement applications in both Hong Kong and the Mainland are permitted. This matters for warranty and indemnity claims: a seller with assets split across the boundary can be pursued in both systems in parallel.

The sequence above describes the standard position. Your matter turns on the documents, the jurisdictions actually engaged, and the order of steps – which is where the route is won or lost.

For a structured assessment of your cross-border warranty position and the enforcement route that applies to your deal vehicle, write to us at info@lockhartyip.com.

Does the deal vehicle's jurisdiction change the risk picture?

It does, substantially. Most Asia deals run through a BVI or Cayman holding entity above the operating assets. That choice is made for tax efficiency, administrative flexibility, and the familiarity of the common-law corporate form. But the warranty and indemnity position that a buyer holds is only as strong as the assets available in the covenantor entity and the enforceability of any guarantee or joint-and-several covenant up the chain.

A BVI or Cayman holding entity that has distributed its sale proceeds faces the classic clean-exit enforcement problem. The buyer's warranty claim runs against a shell. W&I insurance was designed precisely for this scenario, but the insurance recovery is only as strong as the policy terms – the definition of "knowledge", the exclusion list, the retention, and the process for notifying and particularising a claim. Each of those policy mechanics has a direct counterpart in the warranty and indemnity schedule of the SPA itself, and misalignment between the two documents is the most common source of coverage gaps our desk identifies.

Consider a scenario that captures the practical problem. A European strategic acquirer acquired a mid-market Mainland-China consumer business through a Cayman holding company in late 2024. The SPA was governed by Hong Kong law. W&I insurance was placed on a buy-side basis. Within eighteen months, a tax indemnity issue emerged – a pre-signing value-added-tax position that the seller had not disclosed. The insurer's position was that the tax indemnity was excluded under the policy's tax-specific exclusions. The buyer's position was that the disclosure letter had not in fact made a qualifying disclosure. The dispute was not about whether a liability existed; it was about whether the liability ran against the insurer or against the seller, and whether the seller's knowledge qualified under the policy definition. The matter turned on a single sentence in the disclosure letter and the mapping between "seller's knowledge" in the SPA and "insured's awareness" in the policy. Structural misalignment between the two documents – not the underlying liability – was the principal risk.

How does the comparative read differ across common-law and civil-law deal environments in Asia?

In a Hong Kong or Singapore-governed deal, the common-law warranty regime operates as practitioners in the London market would recognise it. The duty to disclose operates through the disclosure letter, specific disclosures qualify general warranties, and the measure of damages for breach of warranty is the difference in value between what was warranted and what was actually delivered. This framework is settled, predictable, and well-suited to W&I insurance because the policy can be calibrated to the SPA's risk allocation with reasonable precision.

The position changes when the deal involves a Mainland-China seller operating under a domestic transaction structure. PRC law does not have an equivalent common-law warranty regime. Representations made by a Mainland seller in a cross-border SPA are often not the product of the same due-diligence-based risk allocation exercise that produces a London or Hong Kong warranty schedule. A Mainland seller may accept warranties in a cross-border SPA without fully appreciating the range of disclosure obligations those warranties carry. The disclosure exercise may be compressed or conducted primarily in Mandarin against records held by an audit team that does not have cross-border SPA experience.

This creates a knowledge asymmetry that is structural, not just transactional. The buyer's W&I insurer will price the underwriting on the quality of the due diligence report, the granularity of the disclosure, and the track record of the management team in prior transactions. A Mainland target with compressed diligence, a thin disclosure letter, and management who have not been through a prior cross-border sale will carry a materially different risk profile than a seasoned PE-backed business with IFRS accounts and a clean data room. The W&I premium, retention, and exclusion list will reflect that difference.

Southeast Asian deal environments vary further. Deals in Indonesia, Vietnam, and the Philippines involve regulatory approval regimes, foreign-ownership restrictions, and sector-specific licences that sit outside the warranty and indemnity framework but directly affect the value that the warranty is trying to protect. A warranty that the company holds all necessary licences means very little if the licensing process is opaque, the licences are not transferable, or the regulator's consent to the change of control has not been obtained. Our cross-border practice frequently sees deals where the W&I policy excludes regulatory approvals not obtained before signing – a gap that is catastrophic if the licence turns out to be non-transferable post-completion.

Where does foreign counsel typically misread the cross-border warranty position?

Three errors recur. The first is treating the warranty and indemnity schedule as self-contained. In a purely domestic common-law deal, the SPA warranty schedule and the disclosure letter together define the buyer's risk position. In a cross-border Asia deal, the same documents sit within a structure that includes the deal vehicle's corporate law, the governing law of any intercompany agreements, the enforcement route, and the W&I policy. A warranty that the seller has good title to the shares of the Mainland operating entity is worth examining against the target's gongshang dengji (Chinese business registration) records, the FDI approval history, and any pledge registers that may not appear in the data room.

The second error is underestimating the interaction between the warranty regime and the deal structure itself. Where the deal uses an earnout – deferred consideration tied to future performance – the warranty and indemnity risk is compounded by a continuing relationship between the parties. A warranty breach that reduces EBITDA in the earnout period is simultaneously a claim under the SPA and a reduction in the deferred purchase price. The documents need to address which claim takes priority and how overlapping recoveries are handled. See our analysis of earn-outs and deferred consideration across borders for the full position on that interface.

The third error – the one that causes the most expensive outcomes – is failing to map the W&I policy to the SPA before signing. W&I insurers underwrite the risk as disclosed in the SPA and the disclosure letter. If the policy is placed after the SPA is substantially agreed, and the policy terms diverge from the SPA's warranty definitions, the gap becomes the buyer's uninsured retention. The most common divergence points are: (a) the definition of seller's knowledge and how it maps to the policy's awareness test; (b) the tax warranty exclusions in the policy versus the scope of the tax indemnity in the SPA; and (c) the treatment of matters disclosed in a data room that are not reflected in specific disclosures in the disclosure letter.

If an earlier filing, structure, or enforcement attempt produced an adverse or stalled result, a second read can identify the strategic error and the routes still open.

To discuss how the warranty and indemnity position applies to your cross-border deal structure, contact info@lockhartyip.com.

What does W&I insurance actually cover in the Asia market, and what does it not?

A buy-side W&I policy in an Asia deal covers warranty breaches by the seller that were unknown to the buyer at the time of signing. The policy responds when a warranted fact turns out to be untrue and the buyer suffers a loss measured by the diminution in value of the target or the actual cost of remediation. The policy does not replace the indemnity regime for identified pre-signing liabilities – those should be addressed by specific indemnities in the SPA, backed where possible by escrow, retention, or seller covenant strength.

Standard exclusions in the Asia W&I market include: matters disclosed in the data room but not in the disclosure letter; forward-looking warranties (revenue projections, pipeline commitments); penalties and punitive damages; secondary tax (i.e., tax arising from the transaction itself rather than pre-signing business conduct); purchase-price adjustments; and, frequently, certain environmental and regulatory compliance warranties. The exclusion list expands for Mainland-China targets, where additional carve-outs for local regulatory compliance, anti-corruption warranties, and VIE structure integrity are common.

VIE structures – variable interest entity (a contractual arrangement used to give offshore investors economic exposure to PRC-restricted industries without formal equity ownership) – present a specific W&I challenge. A warranty that the VIE structure is valid and enforceable is, from an insurer's perspective, nearly impossible to underwrite fully, because the structural validity of VIE arrangements under PRC law remains a matter of regulatory risk rather than settled legal principle. Insurers will typically exclude or heavily restrict coverage for VIE-specific warranties. The buyer's protection in a VIE deal must come from the SPA structure itself – from the robustness of the contractual arrangements, the regulatory compliance history, and, where available, sector-specific clearances.

How does the enforcement route affect the deal negotiation?

Enforcement is not a post-signing concern. It should shape the negotiation from the first term sheet. A warranty claim that cannot be enforced is commercially worthless, and the parties' negotiating positions on warranty scope, disclosure standards, and W&I insurance terms should reflect the enforcement reality.

Under the current regime, a Hong Kong judgment against a Mainland-domiciled seller is registrable in the Mainland courts under Cap. 645 – this is a material improvement over the pre-2024 position, which required an exclusive jurisdiction agreement. But registration is not automatic; it proceeds by application, and the Mainland courts will examine whether the judgment falls within the scope of the ordinance's exclusion list and whether any ground for refusal of recognition applies. The process takes time. A seller with assets in multiple Mainland provinces creates a separate enforcement step in each location.

For an arbitration clause, the position is governed by the 1999 Arrangement and the 2020 Supplemental Arrangement, with the 2021 amendment permitting simultaneous enforcement. An ad hoc arbitration clause – one that does not designate a recognised institution – carries enforcement risk that a clause referencing the HKIAC Administered Arbitration Rules does not. Our practice consistently sees this difference in deals where Mainland sellers propose institutional flexibility; the buyer's enforcement position is materially better under an institutional rule set with a Hong Kong seat.

The decision matrix runs as follows. A deal with a seller who has Mainland-situated assets and no W&I insurance requires: a strong indemnity regime with identified risk categories; a cash escrow held in Hong Kong or offshore; Hong Kong-seated arbitration under the HKIAC Administered Arbitration Rules; and a guarantee from a creditworthy parent entity if the selling vehicle is a special purpose company. A deal with buy-side W&I insurance requires all of the above except the escrow, which can be reduced, but requires careful alignment between the SPA and the policy on knowledge definitions, disclosure standards, and claim notification procedures. A deal with a Southeast Asian target under foreign-ownership restrictions requires, additionally, a regulatory approval condition precedent and a specific indemnity for any licence transferability failure.

See also the firm's work on minority protections in cross-border joint ventures, where many of the same structural challenges arise in a joint-venture context rather than a clean acquisition.

Our read: where does the structural risk sit now?

The structural risk in Asia W&I deals has shifted since the reciprocal-enforcement regime took effect. The enforcement gap for Mainland-seated seller assets is now materially narrower than it was under the 2008 framework. That is a genuine improvement for buyers and their insurers. However, three risk concentrations have not resolved.

First, the W&I insurance market in Asia is hardening on Mainland-China targets. Premium retention levels are moving upward for deals with VIE structures, compressed diligence timelines, or management teams without prior transaction experience. Buyers who structured their deal economics around a specific W&I premium level may find the actual policy economics force a renegotiation of the seller indemnity package or the escrow requirement.

Second, the alignment problem between the SPA and the W&I policy has not reduced; if anything, the increasing use of deal-specific policy language has created more variation in coverage terms across transactions, making the policy-to-SPA mapping exercise more demanding. The gap between a seller's disclosure exercise and the policy's awareness test remains the primary source of uninsured warranty-breach losses that our desk identifies in post-completion disputes.

Third, the regulatory approval interface – particularly in Mainland China under the current foreign-investment review environment, and in Southeast Asian markets with evolving foreign-ownership thresholds – continues to create liability exposure that sits outside the W&I framework. A deal that closes with a pending regulatory approval, or with a licence whose transferability has not been definitively confirmed, is carrying a category of risk that neither the warranty schedule nor the W&I policy can fully address.

The implication for deal teams is direct. The warranty, indemnity, and insurance structure should be mapped against the enforcement route and the regulatory position before the term sheet is agreed, not after the disclosure letter has been delivered. Front-loading the structural analysis is where value is preserved.

Our practice at Lockhart & Yip covers cross-border M&A across the Greater China corridor and into Southeast Asia and the Gulf. We act alongside locally licensed firms where Hong Kong or Mainland law execution is required. For a structured read on your transaction's warranty, indemnity, and insurance position, write to us at info@lockhartyip.com.

See our practice overview at M&A & Transactions for the full scope of cross-border deal work we handle.

Related practices

• Holding Structures – deal vehicle selection, BVI and Cayman entities, holding structure optimisation
• Disputes & Arbitration – post-completion warranty disputes, HKIAC arbitration, enforcement across jurisdictions

Speak with Lockhart & Yip

For a scoped view of your matter, contact info@lockhartyip.com. Discuss your matter →

Related

• Ma Transactions
• Minority Protections Uae Joint Venture Uae
• Earn Outs Deferred Consideration Across Borders Guide

This publication is general information and does not constitute legal advice. For advice on your situation, contact info@lockhartyip.com.